Role of Thioredoxin-Interacting Protein in Diabetic Fatty Kidney Induced by Advanced Glycation End-Products.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of agricultural and food chemistry"
DOI: 10.1021/acs.jafc.1c03559
Abstract: Advanced glycation end-products (AGEs) have been identified as the etiological factors associated with the fatty kidney. Thioredoxin-interacting protein (TXNIP) might be a mediator involved in AGE-induced fatty kidney. This study focused on investigating how TXNIP… read more here.
Keywords: age; fatty kidney; glycation end; advanced glycation ... See more keywords
Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease
Sign Up to like & getrecommendations! Published in 2024 at "European Journal of Clinical Investigation"
DOI: 10.1111/eci.14330
Abstract: Obesity is a growing epidemic affecting approximately 40% of the adult population in developed countries with major health consequences and comorbidities, including diabetes mellitus and insulin resistance, metabolically associated fatty liver disease, atherosclerotic cardiovascular and… read more here.
Keywords: disease; kidney disease; dual agonist; fatty kidney ... See more keywords